Condition: Obstructive Hypertrophic Cardiomyopathy · Sponsor: Shandong Suncadia Medicine Co., Ltd.
The study is being conducted to evaluate the efficacy and safety of HRS-1893 for obstructive hypertrophic cardiomyopathy.
This description comes directly from the study's public registry record.
Yun Jin · +86-0518-82342973 · yun.jin.yj1@hengrui.com
Always discuss trial participation with your own doctor first.
| Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College | Beijing, Beijing Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07021976